Pharmaceutical distribution Industry, Drug wholesaling Industry

Pharmaceutical distributors, drug wholesalers, etc.

I   Medical Care and Society to Go Along With COVID-19

1. Medical Care and Society Being Confused by Expansion of COVID-19 Infections

• Expanded infections within a short period of time
• Issues that have become clear from COVID-19 pandemics
• Countries do not know what have been effective to cure the disease
• Patients at medical institutions and pharmacies significantly decreased, which significantly deteriorated the management conditions of hospitals and other medical institutions
• Japan has been revealed to be vulnerable in stopping expansion of infections
• Infectious Disease Law became the bottleneck to delay the strengthening of PCR testing structure
• Reassessment of supply chains dependent on China
• Business management issues that have been revealed by COVID-19 pandemics
• "New Normal" in the era to go along with COVID-19
• DX in progress in the Japanese companies

2. Report on Revision of the Medical Payment System for FY2020
3. Consumption Tax Hike to 10% Has Achieved Finally
4. Current Status and Future Forecast regarding Online Medical Care
5. Opinions Not to Revise NHI Price during In-Between Year Have Strengthened

II   Medical Care under New Normal

• Medical institutions have become cornered by COVID-19 infections
• How hospitals and clinics should be in the "With Corona" era
• Pharmacies and pharmacists were low profile in the COVID-19 infected society
• How pharmacies should be in the "With Corona" era
• Digitization has been accelerated in pharmaceutical companies triggered by COVID-19 infections
• How pharmaceutical companies should be in the "With Corona" era

III   Drug Wholesalers Able to Survive in "New Normal"

• Pharmaceutical distribution market became confused in the unpredictable situation
• Can the market adapt to "New Normal?"
• The most feasible drug wholesaler that can adapt to the changes
• How drug wholesalers should be in the "With Corona" era